» Articles » PMID: 28243270

Design and Synthesis of Pyrrolo[2,1-a]Isoquinoline-Based Derivatives As New Cytotoxic Agents

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2017 Mar 1
PMID 28243270
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A new series of anti-cancer agents based on 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline scaffold containing N,N-diethylamino-ethoxy, piperidinyl-ethoxy or morpholinyl-ethoxy group at the position of the C-2 phenyl ring were synthesized and their cytotoxic activities were assessed against several human cancer cell lines including MCF-7 (ER positive breast cancer cell), MDA-MB231 (ER-negative breast cancer cell), T47D (Human ductal breast epithelial tumor cell line), A549 (adenocarcinomic human alveolar basal epithelial cells), and Hela (human cervix adenocarcinoma cells) using MTT assay. Based on results, compounds, 1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-5,6-dihydro-8,9-dimethoxy-2-phenylpyrrolo[2,1-a]isoquinoline (6a) and 2-(4-(5,6-dihydro-8,9-dimethoxy-2-phenylpyrrolo[2,1-a] isoquinolin-1-yl)phenoxy)-N,N-diethylethanamine (6c) were the most potent cytotoxic compounds and more toxic than the reference compound against T47D cell line, while all the compounds had satisfactory activity against HeLa cell line with mean IC values ranging from 1.93 to 33.84 µM.

Citing Articles

Nature-Inspired 1-Phenylpyrrolo[2,1-]isoquinoline Scaffold for Novel Antiproliferative Agents Circumventing P-Glycoprotein-Dependent Multidrug Resistance.

Nevskaya A, Purgatorio R, Borisova T, Varlamov A, Anikina L, Obydennik A Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675499 PMC: 11054433. DOI: 10.3390/ph17040539.


Pyrrolo[2,1-]isoquinoline scaffolds for developing anti-cancer agents.

Garcia Maza L, Salgado A, Kouznetsov V, Melendez C RSC Adv. 2024; 14(3):1710-1728.

PMID: 38187449 PMC: 10768717. DOI: 10.1039/d3ra07047f.


Design, Synthesis and Biological Evaluation of 1,3-Diphenyl-3-(phenylthio)propan-1-ones as New Cytotoxic Agents.

Bayanati M, Shahhosseini S, H Shirazi F, Farnam G, Zarghi A Iran J Pharm Res. 2022; 20(4):229-237.

PMID: 35194442 PMC: 8842613. DOI: 10.22037/ijpr.2021.114865.15076.

References
1.
Kakhki S, Shahosseini S, Zarghi A . Design, Synthesis and Cytotoxicity Evaluation of New 2-Aryl-5, 6-Dihydropyrrolo[2, 1-a]Isoquinoline Derivatives as Topoisomerase Inhibitors. Iran J Pharm Res. 2014; 13(Suppl):71-7. PMC: 3977055. View

2.
Siciliano M, Barker P, CAILLEAU R . Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 1979; 39(3):919-22. View

3.
Liao S, Hu D, Wang A, Li D . Novel 5, 6-Dihydropyrrolo[2,1-a]isoquinolines as Scaffolds for Synthesis of Lamellarin Analogues. Evid Based Complement Alternat Med. 2011; 2011:103425. PMC: 3151510. DOI: 10.1155/2011/103425. View

4.
Yang J, Hua W, Wang F, Wang Z, Wang X . Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives. Bioorg Med Chem. 2004; 12(24):6547-57. DOI: 10.1016/j.bmc.2004.09.028. View

5.
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View